Medaphor Group PLC Director/PDMR Shareholding (3741K)
December 13 2018 - 2:30AM
UK Regulatory
TIDMMED
RNS Number : 3741K
Medaphor Group PLC
13 December 2018
13 December 2018
MedaPhor Group plc
("MedaPhor" or the "Group" or the "Company")
Director and PCA Dealings
Further to the Company's announcements on 26 November 2018 and
12 December 2018, MedaPhor announces that certain Directors,
persons closely associated ("PCA") with them and an employee have,
following Admission today, acquired a total of 1,847,064 ordinary
shares of 1 pence each in the Company ("Ordinary Shares") via the
Placing:
Name Title Number Value of Resulting Percentage
of Placing Placing shareholding of enlarged
Shares Shares following share capital
subscribed subscribed subscription following
for for subscription
Riccardo Non-Executive
Pigliucci Chairman 117,648 GBP 10,000.08 117,648 0.1%
------------------ ------------ -------------- -------------- ---------------
Chief Executive
Stuart Gall Officer 588,236 GBP 50,000.06 628,236 0.4%
------------------ ------------ -------------- -------------- ---------------
Wilson Jennings Finance Director 294,118 GBP 25,000.03 294,118 0.2%
------------------ ------------ -------------- -------------- ---------------
Nicholas Chief Technology
Sleep Officer 176,471 GBP 15,000.04 226,471 0.1%
------------------ ------------ -------------- -------------- ---------------
Chief Operating
Ian Whittaker Officer 117,648 GBP 10,000.08 349,982 0.2%
------------------ ------------ -------------- -------------- ---------------
Non-Executive
Nick Avis* Director 141,177 GBP 12,000.06 341,177 0.2%
------------------ ------------ -------------- -------------- ---------------
Non-Executive
Andrew Barker Director 117,648 GBP 10,000.08 317,992 0.2%
------------------ ------------ -------------- -------------- ---------------
* Nick Avis' subscription has been made via his children: Alice
Avis, Florence Avis and Harriet Avis who have each subscribed for
47,059 Placing Shares. Alice, Florence and Harriet are considered
to be persons closely associated with Nick Avis.
The Company makes the following disclosures in accordance with
article 19(3) of the Market Abuse Regulation:
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name 1. Riccardo Pigliucci
2. Stuart Gall
3. Wilson Jennings
4. Nicholas Sleep
5. Ian Whittaker
6. Alice Avis
7. Florence Avis
8. Harriet Avis
9. Andrew Barker
-------------------------- ----------------------------------------
2 Reason for the notification
--------------------------------------------------------------------
a) Position/status 1. Non-Executive Chairman
2. Chief Executive Officer
3. Finance Director
4. Chief Technology Officer
5. Chief Operating Officer
6. Person closely associated with Nick
Avis (Non-Executive Director)
7. Person closely associated with Nick
Avis (Non-Executive Director)
8. Person closely associated with Nick
Avis (Non-Executive Director)
9. Non-Executive Director
-------------------------- ----------------------------------------
b) Initial notification Initial
/Amendment
-------------------------- ----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name MedaPhor Group plc
-------------------------- ----------------------------------------
b) LEI 213800K4ZVWL4ZYQAZ70
-------------------------- ----------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------
a) Description of the Ordinary Shares of 1 pence each
financial instrument,
type of instrument
ISIN: GB00BN791Q39
Identification code
-------------------------- ----------------------------------------
b) Nature of the transaction Purchase of Ordinary Shares
-------------------------- ----------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
1. 8.5 pence 1. 117,648
2. 8.5 pence 2. 588,236
3. 8.5 pence 3. 294,118
4. 8.5 pence 4. 176,471
5. 8.5 pence 5. 117,648
6. 8.5 pence 6. 47,059
7. 8.5 pence 7. 47,059
8. 8.5 pence 8. 47,059
9. 8.5 pence 9. 117,648
------------
-------------------------- ----------------------------------------
d) Aggregated information
- Aggregated volume N/A - single transaction
- Price
-------------------------- ----------------------------------------
e) Date of the transaction 13 December 2018
-------------------------- ----------------------------------------
f) Place of the transaction London Stock Exchange, XLON
-------------------------- ----------------------------------------
Enquiries:
MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Wilson Jennings, CFO
Cenkos Securities - Nominated Tel: +44 (0)20 7397 8900
Advisor and broker
Mark Connelly / Cameron MacRitchie
(Corporate Finance)
Michael Johnson / Julian Morse
(Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com
Anna Dunphy / Paul McManus Mob: +44 (0)7876 741 001 / Mob:
+44 (0)7980 541 893
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLIFFTFTLVLIT
(END) Dow Jones Newswires
December 13, 2018 03:30 ET (08:30 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024